Repurposing Research to Improve Patient Outcomes in Meniere's Disease and Related Diagnoses: Clinical and Preclinical Projects RFP Grant
Funding Amount
Up to US $350,000
Deadline
Deadline not published
Grant Type
Foundation
Overview
Cures Within Reach (CWR) is seeking proposals for clinical and preclinical projects aimed at repurposing therapies to improve patient outcomes in Meniere's disease and related conditions. The focus is on trials that can reduce symptoms, restore function, or minimize side effects from existing treatments. Funding is available for clinical trials up to $350,000 and preclinical research up to $100,000. Collaborations with accredited institutions are encouraged to foster innovative solutions.
Repurposing Research to Improve Patient Outcomes in Meniere's Disease and Related Diagnoses: Clinical and Preclinical Projects RFP
This Request for Proposals (RFP) from Cures Within Reach (CWR) is seeking collaborative, multisite clinical repurposing trials to address Meniere’s disease, as well as other related vertigo and hearing loss-related diagnoses, such as benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis, to improve patient outcomes and quality of life. CWR may also accept translational preclinical repurposing studies that are designed to advance repurposed therapies to clinical trials or combination preclinical/clinical studies that together produce robust data for publications, presentations, follow on funding and potential off label use of repurposed therapies. Submissions can come from accredited academic, nonprofit and governmental research institutions and/or health systems significantly involved with medical research located anywhere in the world.
CWR is interested in generic or proprietary approved therapies that could be repurposed to create “new” treatments that:
reduce the symptoms, progression or incidence of;restore function lost to; orreduce or eliminate severe side effects from current therapies for Meniere’s disease and other vertigo and hearing-loss diagnoses.
Funding
For clinical repurposing trials (budgets up to $350,000) and preclinical repurposing research (budgets up to $100,000) in Meniere’s disease as well as other vertigo and hearing loss-related diagnoses, including benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis. . Submitted budgets must include the required institutional match.
What Partnership for Cures actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 7
- Total given
- $385K
- Median grant
- $60K
- Range
- $15K–$90K
- By dollars: Illinois 49%, Colorado 16%, California 16%. Top recipient cities: Chicago, IL; Denver, CO; Davis, CA.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
University of Illinois · Chicago, IL
Reserach/Clinical Trials
$90K
University of Chicago · Chicago, IL
Reserach/Clinical Trials
$80K
University of Colorado - Denver · Denver, CO
Reserach/Clinical Trials
$60K
University of California Davis · Davis, CA
Reserach/Clinical Trials
$60K
The Washington University St Louis · St Louis, MO
Reserach/Clinical Trials
$60K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Bronchoscopy Research Grant
Intuitive Foundation
Amount
Up to US $75,000
Deadline
January 4, 2027
Listed date — confirm with the funder
Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$6,600,000 total
Deadline
January 8, 2027
George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health
Amount
$5,300,000 total
Deadline
February 1, 2027
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,000,000 total
Deadline
March 5, 2027
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$1,500,000 total
Deadline
March 5, 2027
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2028
Ready to apply for Repurposing Research to Improve Patient Outcomes in Meniere's Disease and Related Diagnoses: Clinical and Preclinical Projects RFP Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Repurposing Research to Improve Patient Outcomes in Meniere's Disease and Related Diagnoses: Clinical and Preclinical Projects RFP Grant. Now let's win it.